These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11654243)

  • 21. Chakrabarty: tempest in a test tube.
    Green HP
    Hastings Cent Rep; 1980 Oct; 10(5):12-3. PubMed ID: 11643615
    [No Abstract]   [Full Text] [Related]  

  • 22. Designer genes that don't fit: a tort regime for commercial releases of genetic engineering products.
    Harv Law Rev; 1987 Mar; 100(5):1086-105. PubMed ID: 11658845
    [No Abstract]   [Full Text] [Related]  

  • 23. Abortion policy in the post-Webster age.
    Halva-Neubauer G
    Publius; 1990; 20(3):27-44. PubMed ID: 11656128
    [No Abstract]   [Full Text] [Related]  

  • 24. U.S. compromises on genetic engineering controls.
    New Sci; 1981 Apr; 90(1251):268. PubMed ID: 11664139
    [No Abstract]   [Full Text] [Related]  

  • 25. You shall be as gods.
    Powledge TM
    Worldview; 1977 Sep; 20(9):45-7. PubMed ID: 11661489
    [No Abstract]   [Full Text] [Related]  

  • 26. The emerging federalism of U.S. biotechnology policy.
    Webber DJ
    Politics Life Sci; 1995 Feb; 14(1):65-72. PubMed ID: 11654872
    [No Abstract]   [Full Text] [Related]  

  • 27. Patenting biology: DNA and oil-eaters.
    Sci News; 1978 Mar; 113(11):167+. PubMed ID: 11661560
    [No Abstract]   [Full Text] [Related]  

  • 28. Special informed consent requirements are included in protocol review procedures.
    Maloney DM
    Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
    [No Abstract]   [Full Text] [Related]  

  • 29. AIDS in the workplace: public and corporate policy.
    Heacock MV; Orvis GP
    Harv J Law Public Policy; 1990; 13(2):689-713. PubMed ID: 11656268
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of vaccines to meet public health needs: incentives and obstacles.
    Russell PK
    Risk; 1996; 7(3):239-52. PubMed ID: 11655077
    [No Abstract]   [Full Text] [Related]  

  • 31. Patents showdown.
    Emmott S
    Splice Life; 1998; 4(5):10-1. PubMed ID: 11657658
    [No Abstract]   [Full Text] [Related]  

  • 32. An historical development of patenting microorganisms and genetically engineered animals in the USA and Europe.
    McTaggart RJ
    Eur J Genet Soc; 1996; 2(1):2-14. PubMed ID: 11658254
    [No Abstract]   [Full Text] [Related]  

  • 33. Toward a more perfect union: a federal cause of action for physician aid-in-dying.
    Robichaud TD
    Univ Mich J Law Reform; 1994; 27(2):521-64. PubMed ID: 11656405
    [No Abstract]   [Full Text] [Related]  

  • 34. Testimony opposing "Freedom of Choice Act.
    Alvare H;
    Origins; 1992 Apr; 21(43):692-6. PubMed ID: 11656134
    [No Abstract]   [Full Text] [Related]  

  • 35. Science by quota: P.C. medicine.
    Satel SL
    New Repub; 1995 Feb; 212(9):14, 16. PubMed ID: 11655245
    [No Abstract]   [Full Text] [Related]  

  • 36. Research on recombinant DNA molecules: the regulatory issues.
    Hutt PB
    South Calif Law Rev; 1978 Sep; 51(6):1435-50. PubMed ID: 11661661
    [No Abstract]   [Full Text] [Related]  

  • 37. Recombinant DNA pioneers lower the alarm.
    Norman C
    Sci Gov Rep; 1977 Jul; 7(12):1-3. PubMed ID: 11661486
    [No Abstract]   [Full Text] [Related]  

  • 38. Human cloning and the law.
    Newman SA
    J Biolaw Bus; 1998; 1(3):59-62. PubMed ID: 11657282
    [No Abstract]   [Full Text] [Related]  

  • 39. RU 486 and the politics of drug regulation in the United States and France.
    Kramnick RK
    Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340
    [No Abstract]   [Full Text] [Related]  

  • 40. Environmental protection: ice-minus test stopped yet again.
    Beardsley T
    Nature; 1986 Sep; 323(6083):9. PubMed ID: 11653733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.